The Japan Agency for Medical Research and Development (AMED) was established in 2015 as a national funding agency for medical research and development. Its mission is to promote medical research and development leading to practical applications.
AMED recognizes the importance of global cooperation and has developed partnerships with other research funding agencies and international initiatives to further strengthen our worldwide network.
“AMED promotes integrated research and development in medicine, from basic research to clinical trials. As a GloPID-R member, we strive to facilitate rapid and effective medical R&D as well as to facilitate collaboration with global and regional partners focusing on preparedness for emerging and re-emerging infectious disease outbreaks with pandemic potential.”
Shoji Miyagawa, DVM, MS., GloPID-R co-chair
AMED supports collaborative research projects at our 10 overseas research centers, located in infectious disease endemic areas. These centers are operated by Japanese universities in 7 Asian countries (China, Indonesia, Myanmar, the Philippines, Thailand, Vietnam, India) and 3 African countries (Ghana, Zambia, DRC). Epidemiology, cohort studies and genome sequencing are conducted via these research centers, strengthening human resources and building strong collaboration with local research institutions and government agencies. The work carried out by this program is contributing to the development of new diagnostics, therapeutics and vaccines.
AMED promotes international collaborative research projects on infectious diseases:
Various research projects and activities are ongoing to prepare for, or respond to, future epidemics and pandemics.
In one of these projects, we have established networks among research institutes in Asian countries to promote collaborative research for epidemiological and pathogenic analysis for disease agents and to develop diagnostic tests. This means that accurate and reliable data can be shared among the network countries.
In another project, Japan is working with other Asian countries to develop human resources for clinical trials, to establish systems based on the needs of major hospitals, and build clinical trial networks. In addition, we promote regulatory harmonization, international joint clinical research and clinical trials in Japan and Asian countries.
AMED fosters international collaboration on medical research and development and has forged partnerships with NIH / NAM in the U.S., MRC in U.K., NHMRC in Australia, CIHR in Canada, SEIDI/AEI in Spain, A*STAR in Singapore, NordForsk in Finland, Norway and Sweden, and the Ministry of Health in Lithuania. In addition, AMED participates in various international alliances and consortia to strengthen multilateral collaboration.
AMED is involved in collaborative projects with organizations in approximately 30 different countries, and more than half of these focus on infectious diseases.
The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874667.